| scholarly article | Q13442814 |
| P2093 | author name string | Wei Zhang | |
| Chao Gao | |||
| Russell Broaddus | |||
| Yingmei Wang | |||
| Longhao Sun | |||
| Fengxia Xue | |||
| P2860 | cites work | A systematic screen for micro-RNAs regulating the canonical Wnt pathway | Q21134995 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling | Q24290355 | ||
| R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6 | Q24292884 | ||
| Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo | Q24305423 | ||
| β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis | Q24306274 | ||
| Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta | Q24319688 | ||
| Association of the APC gene product with beta-catenin | Q24322359 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Signal transduction by the Wnt family of ligands | Q24530639 | ||
| An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin | Q24534109 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Wnt/beta-catenin signaling: components, mechanisms, and diseases | Q24630938 | ||
| AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function | Q26865723 | ||
| Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains | Q27633189 | ||
| Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex | Q27640372 | ||
| Crystal Structure of a Full-Length β-Catenin | Q27650057 | ||
| Diabetes and cancer: a consensus report. | Q27686977 | ||
| Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
| Wnt signaling and cancer | Q27860871 | ||
| The Wnt signaling pathway in development and disease | Q27861019 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review | Q28086989 | ||
| Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism | Q28114789 | ||
| Functional interaction between beta-catenin and FOXO in oxidative stress signaling | Q28115106 | ||
| Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway | Q28118992 | ||
| Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity | Q35748395 | ||
| beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome | Q35787682 | ||
| Altering cancer transcriptomes using epigenomic inhibitors | Q35863203 | ||
| Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt/β-catenin signaling | Q35884151 | ||
| Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance | Q35910243 | ||
| Transcription under the control of nuclear Arm/beta-catenin. | Q36483987 | ||
| Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling | Q36606380 | ||
| beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis | Q36622495 | ||
| Glucose metabolism and cancer | Q36625786 | ||
| Function and biological roles of the Dickkopf family of Wnt modulators | Q36672665 | ||
| γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin | Q36732802 | ||
| AMP-activated protein kinase and its downstream transcriptional pathways | Q36756228 | ||
| Wnt signaling in ovarian tumorigenesis | Q36953825 | ||
| Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. | Q36994927 | ||
| Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A | Q37003339 | ||
| Non-conventional Frizzled ligands and Wnt receptors. | Q37119077 | ||
| Causes and consequences of increased glucose metabolism of cancers | Q37181519 | ||
| Wnt signaling and prostate cancer | Q37233002 | ||
| A two-step model for colon adenoma initiation and progression caused by APC loss | Q37251442 | ||
| Selective activation mechanisms of Wnt signaling pathways | Q37390097 | ||
| beta-catenin signaling and cancer | Q28139147 | ||
| E-cadherin-catenin cell-cell adhesion complex and human cancer | Q28142886 | ||
| AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 | Q28145752 | ||
| Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway | Q28217024 | ||
| A repeating amino acid motif shared by proteins with diverse cellular roles | Q28237358 | ||
| Mechanistic insights from structural studies of beta-catenin and its binding partners | Q28249766 | ||
| From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion | Q28256172 | ||
| Functional interaction of beta-catenin with the transcription factor LEF-1 | Q28286884 | ||
| Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex | Q28289996 | ||
| Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain | Q28295415 | ||
| Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta | Q28505773 | ||
| Apc tumor suppressor gene is the "zonation-keeper" of mouse liver | Q28589915 | ||
| Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein | Q28611046 | ||
| The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape | Q28613516 | ||
| XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos | Q28619032 | ||
| FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features | Q28731816 | ||
| The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
| MicroRNA biogenesis: coordinated cropping and dicing | Q29547496 | ||
| Wnt signaling: a common theme in animal development | Q29547527 | ||
| beta-catenin is a target for the ubiquitin-proteasome pathway | Q29547589 | ||
| Nuclear localization of beta-catenin by interaction with transcription factor LEF-1 | Q29614379 | ||
| Epithelial-mesenchymal transitions in development and pathologies | Q29614986 | ||
| Wnt proteins are lipid-modified and can act as stem cell growth factors | Q29615009 | ||
| Towards an integrated view of Wnt signaling in development | Q29615175 | ||
| Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome | Q29616165 | ||
| Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
| arrow encodes an LDL-receptor-related protein essential for Wingless signalling | Q29618701 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| The ubiquitin-proteasome pathway: on protein death and cell life | Q29619270 | ||
| Wnt signalling and its impact on development and cancer | Q29619273 | ||
| Tumor cell metabolism: cancer's Achilles' heel | Q29619809 | ||
| A new member of the frizzled family from Drosophila functions as a Wingless receptor | Q29620189 | ||
| Stabilization of beta-catenin by genetic defects in melanoma cell lines | Q29620190 | ||
| Cadherin cell adhesion receptors as a morphogenetic regulator | Q29620503 | ||
| p53 and microRNA-34 are suppressors of canonical Wnt signaling. | Q30424916 | ||
| Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy | Q30578330 | ||
| Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex | Q31038919 | ||
| A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities | Q33324196 | ||
| The Yin-Yang of TCF/beta-catenin signaling | Q33767101 | ||
| WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling | Q33917543 | ||
| β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance | Q33999619 | ||
| Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells | Q34052780 | ||
| An updated overview on Wnt signaling pathways: a prelude for more | Q34122601 | ||
| The cadherin-catenin adhesion system in signaling and cancer | Q34124023 | ||
| The LDL receptor gene family: signaling functions during development. | Q34141464 | ||
| Wnt signaling in cancer | Q34262857 | ||
| Novel anti-melanoma treatment: focus on immunotherapy | Q34309404 | ||
| Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma | Q34354361 | ||
| R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis | Q34356591 | ||
| Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms | Q34408068 | ||
| Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. | Q34425171 | ||
| beta-catenin: molecular plasticity and drug design. | Q34432898 | ||
| Disruption of epithelial cell-cell adhesion by exogenous expression of a mutated nonfunctional N-cadherin | Q34435297 | ||
| APC, signal transduction and genetic instability in colorectal cancer | Q34568154 | ||
| Roles of the C terminus of Armadillo in Wingless signaling in Drosophila | Q34607599 | ||
| T-cell factors: turn-ons and turn-offs | Q34634821 | ||
| The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. | Q34670501 | ||
| Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours. | Q34832999 | ||
| CD4(+) regulatory T cells in autoimmunity and allergy | Q34987296 | ||
| Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription | Q34995814 | ||
| β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells | Q35058248 | ||
| Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis | Q35073171 | ||
| Natural versus adaptive regulatory T cells | Q35092554 | ||
| Tumor formation by genetic mutations in the components of the Wnt signaling pathway | Q35161748 | ||
| Reducing insulin resistance with metformin: the evidence today | Q35539934 | ||
| Control of immune homeostasis by naturally arising regulatory CD4+ T cells | Q35589845 | ||
| Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation | Q35607137 | ||
| Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification | Q35640925 | ||
| Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect. | Q35666395 | ||
| Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells | Q35685058 | ||
| β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis | Q37634132 | ||
| International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors | Q37809668 | ||
| Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment | Q37824051 | ||
| The mechanisms of cancer immunoescape and development of overcoming strategies | Q37849666 | ||
| Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling | Q37855367 | ||
| β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target | Q37925433 | ||
| New insights into the mechanism of Wnt signaling pathway activation | Q37948190 | ||
| Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers | Q37966605 | ||
| Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects | Q38016107 | ||
| The complex world of WNT receptor signalling | Q38059785 | ||
| The Wnt/β-catenin pathway in ovarian cancer: a review. | Q38152532 | ||
| The potential of targeting Wnt/β-catenin in colon cancer | Q38202202 | ||
| MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin | Q38292616 | ||
| Targeting the canonical Wnt/β-catenin pathway in hematological malignancies | Q38383469 | ||
| A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis. | Q38813747 | ||
| Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer | Q38995243 | ||
| WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. | Q39159584 | ||
| Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism | Q39341317 | ||
| Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila | Q39646951 | ||
| Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. | Q39779371 | ||
| CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis | Q39828285 | ||
| APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression | Q40222206 | ||
| Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors | Q40795419 | ||
| Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity | Q40944056 | ||
| Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin | Q41036974 | ||
| Genomic organization of the human beta-catenin gene (CTNNB1). | Q41215157 | ||
| Molecular and functional analysis of cadherin-based adherens junctions | Q41689344 | ||
| Constitutive activation of Wnt signaling favors generation of memory CD8 T cells | Q41830072 | ||
| Cadherin-catenin expression in primary colorectal cancer: a survival analysis | Q41936644 | ||
| Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism | Q42396920 | ||
| Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect. | Q42421244 | ||
| {beta}-Catenin regulates airway smooth muscle contraction | Q43062306 | ||
| Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth | Q43211413 | ||
| Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer | Q43279512 | ||
| Regulation of beta-catenin structure and activity by tyrosine phosphorylation. | Q43560193 | ||
| beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas | Q43625618 | ||
| Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function | Q43964066 | ||
| Down-regulation of Wnt signaling during apoptosis of human hepatic stellate cells | Q44237961 | ||
| Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas | Q45345260 | ||
| Abnormalities of the APC/beta-catenin pathway in endometrial cancer | Q45345268 | ||
| Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. | Q45917014 | ||
| Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression | Q46830896 | ||
| Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb | Q47070747 | ||
| Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity | Q47072438 | ||
| Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors | Q48587399 | ||
| R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling | Q50336904 | ||
| Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer. | Q51010316 | ||
| Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. | Q51981689 | ||
| Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. | Q52580091 | ||
| Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. | Q53155856 | ||
| Frequent nuclear accumulation of beta-catenin in pituitary adenoma. | Q53402664 | ||
| Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. | Q53435681 | ||
| Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. | Q53541681 | ||
| Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. | Q53987289 | ||
| Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. | Q54350088 | ||
| Beta-catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin | Q56765450 | ||
| Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia | Q57240019 | ||
| An HMG-box-containing T-cell factor required for thymocyte differentiation. | Q59058515 | ||
| Endometrial cancer | Q63199203 | ||
| Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain | Q68100371 | ||
| Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial cancer: frequent mutations at codon 34 that cause nuclear accumulation | Q73442031 | ||
| Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas | Q73713943 | ||
| Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation | Q73787446 | ||
| Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation | Q73820441 | ||
| Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways | Q74591017 | ||
| High frequency of beta-catenin mutations in hepatoblastoma | Q74819858 | ||
| Beta-catenin mutation in carcinoma of the uterine endometrium | Q77168361 | ||
| CTNNB1 mutations and beta-catenin expression in endometrial carcinomas | Q77951578 | ||
| Nuclear localization of beta-catenin in normal and carcinogenic endometrium | Q78015141 | ||
| beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours | Q78032754 | ||
| Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells | Q79074175 | ||
| SnapShot: Noncanonical Wnt Signaling Pathways | Q80411299 | ||
| beta-Catenin and plakoglobin N- and C-tails determine ligand specificity | Q80593743 | ||
| Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells | Q80622205 | ||
| beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas | Q82086792 | ||
| [Adoptive immunotherapy using gene-modified T cells to express target-specific receptors against hematological malignancy] | Q85721521 | ||
| Blending hippo and WNT: sharing messengers and regulation | Q85763462 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5492-5508 | |
| P577 | publication date | 2017-11-24 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Exon 3 mutations of CTNNB1 drive tumorigenesis: a review | |
| P478 | volume | 9 |
| Q94526207 | Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis |
| Q101121055 | Analysis of open chromatin regions in bladder cancer links β-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer |
| Q58116691 | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
| Q92813709 | Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective |
| Q90375307 | DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1 |
| Q57797059 | GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): a novel CTNNB1 rearrangement |
| Q92128760 | Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing |
| Q90188793 | Histopathology of parasellar neoplasms |
| Q90720640 | Human Colorectal Cancer from the Perspective of Mouse Models |
| Q96231377 | Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection |
| Q98303389 | LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway |
| Q95660385 | Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy |
| Q102141804 | Mutational drivers of cancer cell migration and invasion |
| Q96431876 | Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium |
| Q89882615 | Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases |
| Q91934089 | Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases |
| Q89720874 | Proteogenomic Characterization of Endometrial Carcinoma |
| Q90642640 | Regulatory Mechanism of ITGBL1 in the Metastasis of Colorectal Cancer |
| Q90736869 | Salivary ghost cell carcinoma: case report and proposal of a new entity |
| Q90731855 | TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations |
| Q95294052 | Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions |
| Q89553666 | Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D |
| Q102053996 | WNK regulates Wnt signalling and β-Catenin levels by interfering with the interaction between β-Catenin and GID |
| Q92783226 | Wnt Signaling Pathways in Keratinocyte Carcinomas |
| Q91910450 | Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis |
Search more.